(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

P PEREGRION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

P PEREGRION

ST13

US500000079373203

Class

42

Filing

79373203

Registration

7616674

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

12/24/2024

Trademark type

Combined

Nice classes

42

Filing date

05/23/2023

Registration date

12/24/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/24/2024

Last transaction

12/24/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

26

Owner location

NL

Examiner

STADELI, MARTA ANN

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording "P PEREGRION" with the letter "P" created by a design of a stylized bird with an outstretched wing with the design in gradient shades of blue, changing from dark blue to medium blue and then light blue moving from left to right and bottom to top, and centered below the "P" design is the wording "PEREGRION" in black font, and with the entire design and wording being on a white background.

Holders and representatives

Holders

AMS Microtracer B.V.

Representatives

Brent E. Routman Merchant & Gould, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and pharmaceutical research services in the field of drug development; scientific research and laboratory research relating to pharmaceuticals; scientific research and laboratory research in the field of gene expression; consultancy relating to research in the field of pharmacogenetics; research and development in the field of biotechnology; pharmaceutical research and development; laboratory servicespreparation of biological samples for testing and analyzing in research laboratorities

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/24/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/24/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/22/2024

PUBO

PUBLISHED FOR OPPOSITION

10/22/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/02/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

09/12/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/12/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

09/12/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/12/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/14/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/14/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/14/2024

RFNT

REFUSAL PROCESSED BY IB

04/08/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/16/2024

RFRR

REFUSAL PROCESSED BY MPU

03/16/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/24/2024

CNRT

NON-FINAL ACTION WRITTEN

02/23/2024

DOCK

ASSIGNED TO EXAMINER

02/15/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/11/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/07/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/06/2023

Continuous trademark protection

Get notified about every new filing that threatens P PEREGRION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.